Tiger Medicine 3 drivers get options Dong says no more secrets than red envelopes

Recently, the Zhejiang stock of Tiger Medicine thrown out of an equity incentive plan, quickly become the market focus. The plan says the company intends to issue 3 million share options to middle managers and core personnel, and in this list of 173 motivated subjects, 3 of the people who are "drivers" inspire investors and netizens to watch. Financial profit, demand savings interest rate increase 1000% equity incentives are also known as "golden handcuffs" by the market, which will motivate people to work harder during the incentive period. 　　According to the draft of Tiger Medicine's equity incentive, Chen Ruibo, the senior director of Medical V, has 78,900 stock options, 173 people get the first 2.7 million options, 15,600 per capita, and 3 drivers share options for 7511 shares. Zhejiang stock of Tiger medicine incentive scheme attracted onlookers 3 senior drivers were given the option to say nothing more than the secret of red envelopes "anything is possible, in the listed companies to do a good job, the driver can also get equity incentive" "Equity incentive target is the company's middle management and core technical personnel, drivers are also counted middle and core personnel? "" is not connections, is specially to the chairman, the boss drives the full-time driver, how also calculates a small team leader? ”...... 　　For many questions, the reporter yesterday also interviewed Tiger medicine Dong Cao Xiaochun. "No net friend said so many fishy ah and so on, mainly to motivate the old staff, stabilize the company team, and to encourage young employees." 　　"Cao Xiaochun introduced that the stock rights incentive personnel selection standards are mainly two, one for the director of the above staff, the other is at least 3 years of work, performance assessment of the standard of the old staff. Cao Xiaochun said that the driver generally difficult to become the company in charge of the above middle managers, so the main reference to the equity incentive standards or 3 drivers are a long working experience, performance evaluation of outstanding personnel. 　　The company makes this kind of equity incentive, the goal is to stabilize the team, motivate the old staff or ordinary employees can have a demonstration effect on other employees, conducive to team stability. 　　Cao Xiaochun at the same time, the 3 drivers are not netizens said "connections", nor the chairman, the CEO of the full-time driver, but only the executive department in the course of daily work in the driver of the car. Listed companies to management or core technology, business personnel to carry out equity incentive is very common, but give drivers or drivers such positions to implement equity incentives, before the case is really rare, can be retrieved only another listed company Oriental Rain Rainbow (23.80, 0.09, 0.38% 　　) (002271) issued a draft stock incentive plan on October 11, 2012, including an "executive driver" in the list of incentive targets. However, the Eastern rain Rainbow's line price of 7.03 yuan/share, than the company before the closing close of 14.18 yuan/share discount of more than 50%, for each incentive object is undoubtedly a big "red envelopes." But the tiger Medicine's equity incentive plan, butNot so direct "red envelope effect", even a bit harsh. According to the plan, the equity incentive to the first line of the right price of 54.57 yuan/share, which is slightly above the announcement of the closing close of 54.45 yuan/share. The right condition is: First, take 2012 year operating income as the base, 2013 ~2015 Annual income growth rate is not lower than 26.06%, 60.01% and 104.47% respectively, the second is to 2012 year net profit as the base, 2013 ~2015 annual net profit growth rate is not less than 30%, 　　70.3% and 124.8%, and to deduct the net profit and do not deduct the lower number of the net profit as the basis for calculation. "Overall, the equity incentive will be biased towards the stock price, but some companies are too lenient, so that investors lack of confidence in the development of corporate performance." Tiger Medicine's share incentive, the conditions are relatively high. 　　Analysts point out that, in terms of performance growth and the right price, it is not hard to see the determination and confidence of Tiger medicine, rather than the "red envelopes" that investors have complained about in the past. Reporter further statistics found that this year, a total of 136 companies issued equity incentive plans, has reached the previous release of the largest number of years-2011 annual level. Of these companies, 90 companies have seen their 2012-year performance decline compared with the previous year. A financial analyst explained to reporters that many companies choose in the year of poor performance, as the base year, can reduce the difficulty of the right to do.